世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000029881

細胞免疫療法市場レポート2021-2031

Visiongain

Cellular Immunotherapy Market Report 2021-2031

発刊日 2021/06/08

言語英語

体裁PDF/685ページ

ライセンス/価格685ページ

0000029881

Single - 1 Year License
(Departmental - 5 Users) - 1 Year License
Site
Global

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※シングルユーザーライセンスのレポートは印刷不可、およびライセンス期間は1年となります。
※印刷可能のレポートをご希望の場合は、デパートメントライセンス(ライセンス期間1年、ユーザー数5人)をご検討ください。
※詳しくはお問い合わせください。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

治療法の種類別(CAR-T細胞療法、NK細胞療法、TIL療法、その他)、製品&サービス別(細胞免疫療法製品、細胞免疫療法サービス)、試験アッセイの種類別(バイオアナリティクス、特性評価、バイオセーフティ)、適応症別( B細胞悪性腫瘍、前立腺癌、肝癌、腎細胞癌、その他)、地域&主要国別市場分析に加えて、主要な細胞免疫療法企業の分析およびCOVID-19回復シナリオ

世界の細胞免疫業法市場の概要
Visiongainの分析によると、世界の細胞免疫療法市場は2020年にxx億ドルと推定され、2021年から2031年の予測期間中はxx%のCAGRで成長し、2031年までにxx億ドルに達する見込みです。

レポート詳細

目次

1. Report Overview
1.1 Introduction to Cellular Immunotherapy Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation & Forecast Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2 Executive Summary

3 Market Dynamics
3.1 Drivers for Cellular Immunotherapy Market
3.1.1 Increasing Prevalence of Cancer is driving the Market
3.1.2 Increasing Geriatric Population around the World is Boosting the Demand for Cellular Immunotherapy
3.1.3 Development of Advanced Cellular Immunotherapy is Driving the Cellular Immunotherapy Market
3.1.4 Support from National Cancer Institute for Immunotherapy is estimated to propel the Market Growth
3.2 Restraints for Cellular Immunotherapy Market
3.2.1 Stringent Regulations Associated with Product Development Hinders the Market Growth
3.2.2 High Costs of Cellular Immunotherapy Limits the Market Growth
3.2.3 Complex Supply Chain and Manufacturing Could limit the Entry of New Players
3.3 Opportunities for Cellular Immunotherapy Market
3.3.1 Increasing Demand for the Advanced Cellular Immunotherapy for Cancer Treatment Is Projected to Boost the Market Growth
3.3.2 Mergers, Agreements, and Acquisitions by the Market Players is a Major Trend Witnessed in the Market
3.4 Challenges for Cellular Immunotherapy Market
3.4.1 Adverse Effects associated With Cellular Immunotherapy could Limit its Adoption
3.4.2 Reimbursement Issues for the Advanced Cellular Immunotherapy
3.5 SWOT Analysis for Cellular Immunotherapy Market
3.5.1 Strengths: Cellular Immunotherapy Market
3.5.1.1 Rising Popularity of Cellular Immunotherapy for Cancer Treatment
3.5.1.2 Escalating Clinical-research Infrastructure in Asia Pacific Region
3.5.2 Weaknesses: Cellular Immunotherapy Market
3.5.2.1 Complexity of Cellular Immunotherapies
3.5.2.2 Changing Regulatory Requirements
3.5.3 Opportunities: Cellular Immunotherapy Market
3.5.3.1 Increase in Collaborations between Biopharmaceutical Companies and Academic Research Centers
3.5.3.2 Advantages of CAR-T-Therapy for the Treatment of Liquid Tumors
3.5.4 Threats: Cellular Immunotherapy Market
3.5.4.1 Availability of Alternative Treatment Options
3.5.4.2 Ethical Issues Associated with Cellular Immunotherapy
3.6 Porter’s Five Forces Analysis: Cellular Immunotherapy Market
3.6.1 Bargaining Power of Supplier: High
3.6.2 Bargaining Power of Buyer: Low
3.6.3 Competitive Rivalry: High
3.6.4 Threat of New Entrants: Moderate
3.6.5 Threat of Substitutes: Low
3.7 PEST Analysis: Cellular Immunotherapy Market
3.7.1 Political Factors Impacting Cellular Immunotherapy Market
3.7.2 Economic Factors Impacting Cellular Immunotherapy Market
3.7.3 Social Factors Impacting Cellular Immunotherapy Market
3.7.4 Technological Factors Impacting Cellular Immunotherapy Market

4 COVID-19 Impact: Global Cellular Immunotherapy Market
4.1 Global Cellular Immunotherapy Market Forecast, 2021-2031
4.2 COVID-19 Impact Overview
4.3 "V" shaped Recovery - Rapid Decline - Sharp Borrow -Rapid Recovery
4.4 "U" Shaped Recovery -Rapid Decline Early Then Slow - Gradual at the Bottom - Slow Recovery at First - Faster Recovery Later On
4.5 "W" Shaped Recovery -Rapid Decline - Rapid Recovery- Return of Virus - Another Sharp Decline -Recovery
4.6 "L" Shaped Recovery - Rapid Decline - Then Slow Growth

5 Global Cellular Immunotherapy Market Size Forecast 2021-2031 by Therapy Type
5.1 Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031
5.1.1 CAR-T Cell Therapy is the Largest Revenue Grossing Segment
5.1.2 Recovery Forecasts (V, U, W, L)
5.2 Global NK (Natural Killer) Cell Therapy Segment: Revenue Forecast 2021-2031
5.2.1 NK Cell Lines Offer a Robust Cytotoxicity against Cancer Cells
5.2.2 Recovery Forecasts (V, U, W, L)
5.3 Global Tumor-Infiltrating Lymphocyte (TIL) Therapy Segment: Revenue Forecast 2021-2031
5.3.1 TIL Therapy is a Promising form of Adoptive Cellular Immunotherapy
5.3.2 Recovery Forecasts (V, U, W, L)
5.4 Global Others Segment: Revenue Forecast 2021-2031
5.4.1 Promising Engineered T-Cell Receptor (TCR) and Dendritic Cell (DC)-based Therapies are expected to boost the Other Cell Therapy Segment Growth
5.4.2 Recovery Forecasts (V, U, W, L)

6 Cellular Immunotherapy Market by Product and Services Forecast, 2021-2031
6.1 Global Cellular Immunotherapy Product Segment Market Forecast, 2021-2031
6.1.1 Cellular Immunotherapy Product Segment is showing the Highest CAGR during the Forecast Period
6.1.2 Recovery Scenarios (V, U, W, L)
6.2 Global Cellular Immunotherapy Services Segment Market Forecast, 2021-2031
6.2.1 Rising Investment in Cell-Based Therapies R&D is driving the Cellular Immunotherapy Services Segment
6.2.2 Recovery Scenarios (V, U, W, L)

7 Cellular Immunotherapy Market by Testing Assays Type Forecast, 2021-2031
7.1 Bioanalytics Segment Market Forecast, 2021-2031
7.1.1 Largest-Revenue Growing Segment in the Market
7.1.2 Recovery Scenarios (V, U, W, L)
7.2 Characterization Segment Market Forecast, 2021-2031
7.2.1 Second-Largest Revenue Generating Segment
7.2.2 Recovery Scenarios (V, U, W, L)
7.3 Biosafety Segment Market Forecast, 2021-2031
7.3.1 Well-defined Regulations for the Cellular Therapies in the Developed Countries Is Expected To Drive the Market Growth
7.3.2 Recovery Scenarios (V, U, W, L)

8 Global Cellular Immunotherapy Market Size Forecast 2021-2031 by Indication
8.1 Global B-cell Malignancies Segment: Revenue Forecast 2021-2031
8.1.1 B-cell Malignancies is the Largest Revenue Grossing Segment
8.1.2 Recovery Forecasts (V, U, W, L)
8.2 Global Prostate Cancer Segment: Revenue Forecast 2021-2031
8.2.1 sipuleucel-T (Provenge) has been Approved by the US FDA for the Treatment of Prostate Cancer
8.2.2 Recovery Forecasts (V, U, W, L)
8.3 Global Liver Cancer Segment: Revenue Forecast 2021-2031
8.3.1 Liver Cancer Segment is Expected to Grow at a Lucrative Growth Rate
8.3.2 Recovery Forecasts (V, U, W, L)
8.4 Global Renal Cell Carcinoma Segment: Revenue Forecast 2021-2031
8.4.1 Growing Investment in Cellular Immunotherapy for the Treatment of Renal Cell Carcinoma is projected to Drive the Segment Growth
8.4.2 Recovery Forecasts (V, U, W, L)
8.5 Global Others Segment: Revenue Forecast 2021-2031
8.5.1 Growing Demand for Advanced Drugs Is Expected to Propel the Others Segment Growth
8.5.2 Recovery Forecasts (V, U, W, L)

9 National Cellular Immunotherapy Market Forecast, 2021-2031
9.1 Global Cellular Immunotherapy Market by Region Forecast 2021-2031
9.1 Recovery Scenarios (V, U, W, L)

10 North America Cellular Immunotherapy Market, 2021-2031
10.1 North America is the Largest Revenue Grossing Region in the Global Market
10.2 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.3 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.4 North America Cellular Immunotherapy Market Forecast by Product & Service
10.5 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.6 North America Cellular Immunotherapy Market Forecast by Indication
10.7 Recovery Scenarios (V, U, W, L): North America Market
10.7.1 V-Shaped Recovery
10.7.1.1 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.7.1.2 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.7.1.3 North America Cellular Immunotherapy Market Forecast by Product & Service
10.7.1.4 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.7.1.5 North America Cellular Immunotherapy Market Forecast by Indication
10.7.2 U-Shaped Recovery
10.7.2.1 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.7.2.2 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.7.2.3 North America Cellular Immunotherapy Market Forecast by Product & Service
10.7.2.4 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.7.2.5 North America Cellular Immunotherapy Market Forecast by Indication
10.7.3 W-Shaped Recovery
10.7.3.1 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.7.3.2 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.7.3.3 North America Cellular Immunotherapy Market Forecast by Product & Service
10.7.3.4 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.7.3.5 North America Cellular Immunotherapy Market Forecast by Indication
10.7.4 L-Shaped Recovery
10.7.4.1 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.7.4.2 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.7.4.3 North America Cellular Immunotherapy Market Forecast by Product & Service
10.7.4.4 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.7.4.5 North America Cellular Immunotherapy Market Forecast by Indication
10.8 U.S. Cellular Immunotherapy Market Forecast, 2021-2031
10.8.1 Presence of Leading Players is a Major factor driving the U.S. Cellular Imunotherapy Market
10.8.2 Presence of Highly Developed Healthcare Infrastructure
10.9 Canada Cellular Immunotherapy Market Forecast, 2021-2031
10.9.1 Canada Market Anticipated To Witness the Fastest Growth in the North America Region
10.9.2 Growing Canadian research collaborations determined to Provide Infrastructure for Cell-Based Therapy Research

11 Europe Cellular Immunotherapy Market, 2021-2031
11.1 Second Largest Market in the Global Market
11.2 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.3 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.4 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.5 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.6 Europe Cellular Immunotherapy Market Forecast by Indication
11.7 Recovery Scenarios (V, U, W, L): Europe Market
11.7.1 V-Shaped Recovery
11.7.1.1 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.7.1.2 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.7.1.3 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.7.1.4 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.7.1.5 Europe Cellular Immunotherapy Market Forecast by Indication
11.7.2 U-Shaped Recovery
11.7.2.1 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.7.2.2 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.7.2.3 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.7.2.4 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.7.2.5 Europe Cellular Immunotherapy Market Forecast by Indication
11.7.3 W-Shaped Recovery
11.7.3.1 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.7.3.2 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.7.3.3 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.7.3.4 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.7.3.5 Europe Cellular Immunotherapy Market Forecast by Indication
11.7.4 L-Shaped Recovery
11.7.4.1 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.7.4.2 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.7.4.3 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.7.4.4 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.7.4.5 Europe Cellular Immunotherapy Market Forecast by Indication
11.8 Germany Cellular Immunotherapy Market Forecast, 2021-2031
11.8.1 Growing Geriatric Population In This Region Is Expected To Boost The Regional Market Growth
11.8.2 Rising Focus on CAR-T Cell and NK Cell Therapies R&D in Germany
11.9 UK Cellular Immunotherapy Market Forecast, 2021-2031
11.9.1 Presence of Well-Developed R&D Infrastructure
11.9.2 Rise in Number of Treatment Centers in the UK
11.10 France Cellular Immunotherapy Market Forecast, 2021-2031
11.10.1 Growing Demand for Advanced Healthcare Services
11.10.2 Rising Preference for France for Cellular Therapy R&D and Manufacturing by Leading Players
11.11 Italy Cellular Immunotherapy Market Forecast, 2021-2031
11.11.1 Pharmaceutical Manufacturing Hub
11.11.2 Growing Acceptance of Cellular Therapies for the Treatment of Cancer in Italy is projected to drive the Market Growth
11.12 Spain Cellular Immunotherapy Market Forecast, 2021-2031
11.12.1 Demand for Drugs Is Influenced By the Growth of the Pharmaceutical Industry
11.12.2 Spanish Economy Is Growing Strong
11.13 Russia Cellular Immunotherapy Market Forecast, 2021-2031
11.13.1 Growing Government Support for the Development of Advanced Cancer Therapies
11.13.2 Unmet Pharmaceutical Needs
11.14 Rest of Europe Cellular Immunotherapy Market Forecast, 2021-2031
11.14.1 Increasing Prevalence of Cancer

12 Asia Pacific Cellular Immunotherapy Market, 2021-2031
12.1 Asia Pacific is the Fastest Growing Market
12.2 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.3 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.4 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.5 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.6 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.7 Recovery Scenarios (V, U, W, L): APAC Market
12.7.1 V-Shaped Recovery
12.7.1.1 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.7.1.2 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.7.1.3 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.7.1.4 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.7.1.5 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.7.2 U-Shaped Recovery
12.7.2.1 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.7.2.2 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.7.2.3 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.7.2.4 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.7.2.5 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.7.3 W-Shaped Recovery
12.7.3.1 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.7.3.2 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.7.3.3 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.7.3.4 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.7.3.5 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.7.4 L-Shaped Recovery
12.7.4.1 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.7.4.2 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.7.4.3 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.7.4.4 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.7.4.5 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.8 Japan Cellular Immunotherapy Market Forecast, 2021-2031
12.8.1 Japan Accounted For the Largest Market Share in the Asia Pacific Region
12.8.2 Rising Number of Product Approval is Expected to Drive the Market Growth
12.9 China Cellular Immunotherapy Market Forecast, 2021-2031
12.9.1 Strategic Initiatives Undertaken by the Market Players
12.9.2 Increasing Healthcare Spending In China
12.10 India Cellular Immunotherapy Market Forecast, 2021-2031
12.10.1 Developing Healthcare Infrastructure
12.10.2 Increasing Prevalence of Cancer
12.11 Australia Cellular Immunotherapy Market Forecast, 2021-2031
12.11.1 Government Programs to Expand Access to Quality Healthcare
12.11.2 Launch of Cell-based Therapies in Australia is Projected to Boost the Market Growth
12.12 South Korea Cellular Immunotherapy Market Forecast, 2021-2031
12.12.1 Growing Healthcare Awareness among People
12.12.2 Rising Cancer Incidence is Expected to Drive theSouth Korea Market
12.13 Rest of Asia Pacific Cellular Immunotherapy Market Forecast, 2021-2031
12.13.1 Rising Disposable Income

13 Latin America Cellular Immunotherapy Market, 2021-2031
13.1 Latin America Cellular Immunotherapy Market
13.2 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.3 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.4 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.5 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.6 Latin America Cellular Immunotherapy Market Forecast by Indication
13.7 Recovery Scenarios (V, U, W, L): Latin America Market
13.7.1 V-Shaped Recovery
13.7.1.1 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.7.1.2 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.7.1.3 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.7.1.4 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.7.1.5 Latin America Cellular Immunotherapy Market Forecast by Indication
13.7.2 U-Shaped Recovery
13.7.2.1 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.7.2.2 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.7.2.3 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.7.2.4 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.7.2.5 Latin America Cellular Immunotherapy Market Forecast by Indication
13.7.3 W-Shaped Recovery
13.7.3.1 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.7.3.2 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.7.3.3 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.7.3.4 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.7.3.5 Latin America Cellular Immunotherapy Market Forecast by Indication
13.7.4 L-Shaped Recovery
13.7.4.1 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.7.4.2 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.7.4.3 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.7.4.4 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.7.4.5 Latin America Cellular Immunotherapy Market Forecast by Indication
13.8 Brazil Cellular Immunotherapy Market Forecast, 2021-2031
13.8.1 Fastest Growing Economy in Latin America
13.8.2 High Potential Manufacturing Environment
13.9 Mexico Cellular Immunotherapy Market Forecast, 2021-2031
13.9.1 Lower Manufacturing Costs than In the US
13.9.2 Strategic Initiatives Undertaken By Market Players
13.10 Rest of Latin America Cellular Immunotherapy Market Forecast, 2021-2031
13.10.1 Evolving Healthcare Infrastructure in Latin America

14 MEA Cellular Immunotherapy Market, 2021-2031
14.1 Rising Prevalence of Cancer in MEA Region
14.2 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.3 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.4 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.5 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.6 MEA Cellular Immunotherapy Market Forecast by Indication
14.7 Recovery Scenarios (V, U, W, L): MEA Market
14.7.1 V-Shaped Recovery
14.7.1.1 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.7.1.2 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.7.1.3 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.7.1.4 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.7.1.5 MEA Cellular Immunotherapy Market Forecast by Indication
14.7.2 U-Shaped Recovery
14.7.2.1 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.7.2.2 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.7.2.3 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.7.2.4 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.7.2.5 MEA Cellular Immunotherapy Market Forecast by Indication
14.7.3 W-Shaped Recovery
14.7.3.1 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.7.3.2 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.7.3.3 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.7.3.4 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.7.3.5 MEA Cellular Immunotherapy Market Forecast by Indication
14.7.4 L-Shaped Recovery
14.7.4.1 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.7.4.2 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.7.4.3 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.7.4.4 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.7.4.5 MEA Cellular Immunotherapy Market Forecast by Indication
14.8 South Africa Cellular Immunotherapy Market Forecast, 2021-2031
14.8.1 Prevalence of Cancer in South Africa is Increasing Rapidly
14.8.2 Population Exposed to Mining Suffers from Cancer
14.9 GCC Cellular Immunotherapy Market Forecast, 2021-2031
14.9.1 Presence of Huge Growth Opportunities
14.9.2 Advances in personalised medicine and immuno-oncology have ushered in a paradigm change
14.10 Rest of MEA Cellular Immunotherapy Market Forecast, 2021-2031
14.10.1 Cancer Is One of the Leading Causes of Death
14.10.2 Extensive Tobacco Use Increases Incidence of Cancer

15 Company Profiles: Cellular Immunotherapy Market
15.1 Cellular Immunotherapy Market: Company Share Analysis
15.2 Cellular Immunotherapy Market Recent Developments, 2017-2021
15.3 Novartis AG
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2016-2020
15.3.3.2 Business Segments Revenue Shares, 2020
15.3.3.3 Pharmaceuticals Business Unit Revenue Shares, 2020
15.3.3.4 Regional Revenue Shares, 2020
15.3.4 Product Benchmarking
15.3.5 Recent Developments, 2017-2021
15.4 Gilead Sciences, Inc.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2016-2020
15.4.3.2 Business Segments Revenue Shares, 2020
15.4.3.3 Regional Revenue Shares, 2020
15.4.4 Product Benchmarking
15.4.5 Recent Developments, 2017-2021
15.5 Adicet Bio
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2016-2020
15.5.4 Product Benchmarking
15.5.5 Recent Developments, 2018-2021
15.6 GlaxoSmithKline plc.
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Revenue, 2016-2020
15.6.3.2 Pharmaceutical Business Revenue Share, 2020
15.6.3.3 Regional Revenue Shares, 2020
15.6.4 Product Benchmarking
15.6.5 Recent Developments, 2018-2021
15.7 Pfizer Inc.
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2016-2020
15.7.3.2 Product Revenue Shares, 2020
15.7.3.3 Regional Revenue Shares, 2020
15.7.4 Product Benchmarking
15.7.5 Recent Developments, 2018-2021
15.8 F. Hoffmann-La Roche Ltd.
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2016-2020
15.8.3.2 Product Revenue Shares, 2020
15.8.3.3 Regional Revenue Shares, 2020
15.8.4 Product Benchmarking
15.8.5 Recent Developments, 2018-2021
15.9 Iovance Biotherapeutics, Inc.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Product Benchmarking
15.9.4 Recent Developments, 2018-2021
15.10 Tessa Therapeutics Ltd.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Product Benchmarking
15.10.4 Recent Developments, 2018-2021
15.11 Inovio Pharmaceuticals, Inc.
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2016-2020
15.11.4 Product Benchmarking
15.11.5 Recent Developments, 2018-2021
15.12 AstraZeneca
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2016-2020
15.12.3.2 Product Revenue Shares, 2020
15.12.3.3 Regional Revenue Shares, 2020
15.12.4 Product Benchmarking
15.12.5 Recent Developments, 2018-2021
15.13 Adaptimmune Therapeutics plc.
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue, 2016-2020
15.13.4 Product Benchmarking
15.14 Atara Biotherapeutics, Inc.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Product Benchmarking
15.14.4 Recent Developments, 2018-2021
15.15 Bristol-Myers Squibb Company
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Financial Analysis
15.15.3.1 Net Revenue, 2016-2020
15.15.3.2 Regional Revenue Shares, 2020
15.15.4 Product Benchmarking
15.15.5 Recent Developments, 2018-2021
15.16 APAC Biotech
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Product Benchmarking
15.17 JW shinyak (JW CreaGene)
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Product Benchmarking
15.17.4 Recent Developments, 2018-2021

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players
16.3 Leading Regions and Fastest Growing Region (North America Region Accounted

List of Tables
Table 1 Global Cellular Immunotherapy Market, 2020 & 2031 (US$ bn, CAGR %)
Table 2 Worldwide Cancer Incidence, 2020
Table 3 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031
Table 4 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "V" Shaped Recovery
Table 5 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "U" Shaped Recovery
Table 6 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "W" Shaped Recovery
Table 7 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "L" Shaped Recovery
Table 8 Global Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 9 Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 10 “V” Shaped Recovery: Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 11 “U” Shaped Recovery: Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 12 “W” Shaped Recovery: Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 13 “L” Shaped Recovery: Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 14 Global NK Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 15 “V” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 16 “U” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 17 “W” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 18 “L” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 19 Global TIL Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 20 “V” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 21 “U” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 22 “W” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 23 “L” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 24 Global Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 25 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 26 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 27 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 28 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 29 Global Cellular Immunotherapy Market Forecast by Product and Services, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 30 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 31 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 32 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 33 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 34 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 35 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 36 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 39 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 40 Global Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 41 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 42 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 43 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 44 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 45 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 46 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 47 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 48 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 49 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 50 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 51 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 52 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 53 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 54 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 55 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 56 Global Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 57 Global B-cell Malignancies Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 58 “V” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 59 “U” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 60 “W” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 61 “L” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 62 Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 63 “V” Shaped Recovery: Global B-cell malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 64 “U” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 65 “W” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 66 “L” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 67 Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 68 “V” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 69 “U” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 70 “W” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 71 “L” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 72 Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 73 “V” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 74 “U” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 75 “W” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 76 “L” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 77 Global Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 78 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 79 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 80 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 81 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 82 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 83 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 84 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 85 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 86 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 87 North America Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 88 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 89 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 90 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 91 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 92 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 93 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 94 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 95 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 96 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 97 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 98 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 99 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 100 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 101 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 102 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 103 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 104 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 105 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 106 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 107 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 108 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 109 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 110 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 111 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 112 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 113 U.S. Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 114 Canada Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 115 Europe Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 116 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 117 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 118 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 119 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 120 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 121 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 122 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 123 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 124 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 125 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 126 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 127 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 128 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 129 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 130 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 131 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 132 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 133 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 134 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 135 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 136 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 137 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 138 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 139 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 140 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 141 Germany Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 142 UK Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 143 France Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 144 Italy Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 145 Spain Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 146 Russia Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 147 Rest of Europe Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 148 Asia Pacific Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 149 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 150 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 151 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 152 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 153 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 154 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 155 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 156 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 157 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 158 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 159 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 160 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 161 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 162 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 163 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 164 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 165 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 166 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 167 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 168 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 169 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 170 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 171 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 172 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 173 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 174 Japan Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 175 China Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 176 India Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 177 Australia Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 178 South Korea Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 179 Rest of Asia Pacific Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 180 Latin America Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 181 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 182 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 183 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 184 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 185 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 186 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 187 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 188 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 189 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 190 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 191 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 192 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 193 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 194 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 195 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 196 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 197 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 198 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 199 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 200 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 201 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 202 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 203 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 204 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 205 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 206 Brazil Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 207 Mexico Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 208 Rest of Latin America Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 209 MEA Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 210 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 211 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 212 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 213 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 214 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 215 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 216 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 217 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 218 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 219 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 220 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 221 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 222 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 223 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 224 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 225 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 226 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 227 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 228 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 229 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 230 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 231 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 232 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 233 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 234 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 235 South Africa Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 236 GCC Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 237 Rest of MEA Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 238 Cellular Immunotherapy Market Recent Developments, 2018-2021
Table 239 Novartis AG: Key Details, (MD, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 240 Novartis AG: Product Benchmarking
Table 241 Novartis AG : Recent Developments, 2018-2021
Table 242 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 1 Kite Corporate (Gilead Sciences, Inc.): Product Benchmarking
Table 243 Kite Corporate (Gilead Sciences, Inc.) : Recent Developments, 2018-2021
Table 244 Adicet Bio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 245 Adicet Bio: Product Benchmarking
Table 246 Adicet Bio : Recent Developments, 2018-2021
Table 247 GlaxoSmithKline plc.: Key Details, (MD, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 248 GlaxoSmithKline plc: Product Benchmarking
Table 249 GlaxoSmithKline plc: Recent Developments, 2018-2021
Table 250 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 251 Pfizer Inc.: Product Benchmarking
Table 252 Pfizer Inc. : Recent Developments, 2018-2021
Table 253 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 254 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 255 F. Hoffmann-La Roche Ltd.: Recent Developments, 2018-2021
Table 256 Iovance Biotherapeutics, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website)
Table 257 Iovance Biotherapeutics, Inc.: Product Benchmarking
Table 258 Iovance Biotherapeutics, Inc. : Recent Developments, 2018-2021
Table 259 Tessa Therapeutics Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 260 Tessa Therapeutics Ltd.: Product Benchmarking
Table 261 Tessa Therapeutics Ltd. : Recent Developments, 2018-2021
Table 262 Inovio Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 263 Inovio Pharmaceuticals, Inc.: Product Benchmarking
Table 264 Inovio Pharmaceuticals, Inc.: Recent Developments, 2018-2021
Table 265 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 266 AstraZeneca: Product Benchmarking
Table 267 AstraZeneca : Recent Developments, 2018-2021
Table 268 Adaptimmune Therapeutics plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 269 Adaptimmune Therapeutics plc.: Product Benchmarking
Table 270 Atara Biotherapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 271 Atara Biotherapeutics, Inc.: Product Benchmarking
Table 272 Atara Biotherapeutics, Inc.: Recent Developments, 2018-2021
Table 273 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 274 Bristol-Myers Squibb Company: Product Benchmarking
Table 275 Bristol-Myers Squibb Company: Recent Developments, 2018-2021
Table 276 APAC Biotech: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 277 APAC Biotech: Product Benchmarking
Table 278 JW shinyak (JW CreaGene): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 279 JW shinyak (JW CreaGene): Product Benchmarking
Table 280 JW shinyak (JW CreaGene): Recent Developments, 2018-2021
?

List of Figures
Figure 1 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %)
Figure 2 Global Cellular Immunotherapy Market Segmentation
Figure 3 Global Cellular Immunotherapy Market: Market Trends
Figure 4 Global Cellular Immunotherapy Market: SWOT Analysis
Figure 5 Global Cellular Immunotherapy Market: Porter’s Five Forces Analysis
Figure 6 Global Cellular Immunotherapy Market: PEST Analysis
Figure 7 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %)
Figure 8 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %): "V" Shaped Recovery
Figure 9 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %): "U" Shaped Recovery
Figure 10 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %): "W" Shaped Recovery
Figure 11 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %): "L" Shaped Recovery
Figure 12 Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 13 “V” Shaped Recovery: Global CAR-T Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 14 “U” Shaped Recovery: Global CAR-T Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 15 “W” Shaped Recovery: Global CAR-T Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 16 “L” Shaped Recovery: Global CAR-T Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 17 Global NK Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 18 “V” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 19 “U” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 20 “W” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 21 “L” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 22 Global TIL Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 23 “V” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 24 “U” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 25 “W” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 26 “L” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 27 Global Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 28 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 29 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 30 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 31 “L” Shaped Recovery: Global Others Segment, Revenue

この商品のレポートナンバー

0000029881

TOP